BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34022901)

  • 1. Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.
    Sangho O; Tounkara M; Whiting-Collins LJ; Beebe M; Winch PJ; Doumbia S
    Malar J; 2021 May; 20(1):231. PubMed ID: 34022901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
    Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underreporting and Missed Opportunities for Uptake of Intermittent Preventative Treatment of Malaria in Pregnancy (IPTp) in Mali.
    Hurley EA; Harvey SA; Rao N; Diarra NH; Klein MC; Diop SI; Doumbia SO
    PLoS One; 2016; 11(8):e0160008. PubMed ID: 27494250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey.
    Hill J; Kayentao K; Touré M; Diarwara S; Bruce J; Smedley J; Doumbo OK; ter Kuile FO; Webster J
    PLoS One; 2014; 9(3):e92102. PubMed ID: 24651078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.
    Doumbia I; Seydou F; Diakalia K; Bennis I
    Malar J; 2021 Oct; 20(1):402. PubMed ID: 34656113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent preventive treatment of malaria in pregnancy (IPTp): do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities?
    Ndyomugyenyi R; Katamanywa J
    Trans R Soc Trop Med Hyg; 2010 Aug; 104(8):536-40. PubMed ID: 20227739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
    Awantang GN; Babalola SO; Koenker H; Fox KA; Toso M; Lewicky N
    Malar J; 2018 Apr; 17(1):176. PubMed ID: 29695231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.
    Ameh S; Owoaje E; Oyo-Ita A; Kabiru CW; Akpet OEO; Etokidem A; Enembe O; Ekpenyong N
    BMC Pregnancy Childbirth; 2016 May; 16():99. PubMed ID: 27147109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
    Exavery A; Mbaruku G; Mbuyita S; Makemba A; Kinyonge IP; Kweka H
    Malar J; 2014 Jan; 13():22. PubMed ID: 24423279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.